Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil

Molecular Biology Reports

Volumn 41, Issue 2, 2014, Pages 865-874

  Tavares, Mayara Costa Mansur ^a   De Macêdo, Jamilly Lopes ^b   De Lima, Sérgio Ferreira ^a   De Andrade Heráclio, Sandra ^c   Amorim, Melânia Maria Ramos ^c   De Mascena Diniz Maia, Maria ^d   De Souza, Paulo Roberto Eleutério ^d  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^d UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

Author keywords

Abnormal cytology; Brazilian population; Chlamydia trachomatis; Human papillomavirus; Risk factors

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER GRADING; CANCER RISK; CHLAMYDIASIS; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SMOKING; SOCIAL STATUS; UTERINE CERVIX BIOPSY; UTERINE CERVIX TUMOR; YOUNG ADULT;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADOLESCENT; ADULT; AGED; ANIMALS; BRAZIL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COINFECTION; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84899432386     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2927-2     Document Type: Article

References (70)

1. Stanley M (2008) Immunobiology of HPV and HPV vaccines. Gynecol Oncol 109:15-21. doi:10.1016/j.ygyno.2008.02.003
2. Simonetti AC, Melo JHL, Souza PRE, Bruneska D, Filho JLL (2009) Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 11:435-442. doi:10.1016/j.micinf.2009.01.004
3. Brasil (2012) Ministério da Saúde. Instituto Nacional do Câncer. http://www.inca.gov.br/estimativa/2012/index.asp?ID=5. Accessed 12 June 2012
4. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev Jan 16:1-17. doi:10.1128/CMR.16.1.1-17.2003
5. Kirkpatrick A, Bidwell J, Van den Brule AJC, Meijer CJLM, Pawade J, Glew S (2004) TNFa polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92:675-679. doi:10.1016/j.ygyno.2003.11.025 (Pubitemid 38183162)
6. Van Ranst M, Kaplan JB, Burke RD (1992) Phylogenetic classification of human papillomaviruses: correlation with manifestations. J Gen Virol 73:2653-2660
7. Albring L, Brentano JE, Vargas VRA (2006) O câncer do colo do útero, o Papilomavírus Humano (HPV) e seus fatores de risco e as mulheres indígenas Guarani: estudo de revisão. RBAC 38:87-90
8. Magi JC, Brito SEM, Grecco ETO et al (2006) Prevalência de papilomavirus humano (HPV) anal, genital e oral, em ambulatório geral de coloproctologia. Rev Bras Coloproct 26:233-238. doi:10.1590/S0101- 98802006000300001
9. Magi JC, Magi DAS, Reche LMC et al (2002) Anuscopia com exacerbação para diagnóstico de Papilomavirus humano ano-retal na forma subclínica. Rev bras Coloproct 22:178-183
10. Bosch FX, Burchell AN, Schiffman M et al (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10):K1-K16. doi:10.1016/j.vaccine.2008.05. 064
11. Hausen HZ (2000) Papillomaviruses causing cancer: evasion from host-cell host in early events in carcinogenesis. J Natl Cancer Inst 92:690-698. doi:10.1093/jnci/92.9.690
12. Muñoz N, International Agency for Research on Cancer Multicenter Cervical et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. doi:10.1056/ NEJMoa021641348/6/518 (Pubitemid 36159887)
13. Kjaer SK, Van Der Brule AJ, Paull G et al (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:5722. doi:10.1136/bmj.325.7364.572
14. Josefsson AM, Magnusson PKE, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Anderson PK et al (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189-2193 (Pubitemid 30394325)
15. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S et al (2000) Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 163:503-508
16. Manavi K (2006) A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 20:941-951. doi:10.1016/j.bpobgyn.2006.06.003
17. Giraldo PC, Simões JA (2000) Clamídia e micoplasmas. In: Halbe HW (ed) Tratado de ginecologia, 3rd edn. Roca, São Paulo, pp 1047-1058
18. Seadi CF, Oravec R, Poser BV et al (2002) Diagnóstico laboratorial da infecção pela Chlamydia trachomatis: vantagens e desvantagens das técnicas. J Bras Patol Med Lab 38:125-133. doi:10.1590/S1676- 24442002000200009
19. World Health Organization (2005) Sexually transmitted and other reproductive tract infections. Geneva, World Health Organization. http://www.searo.who.int/LinkFiles/Publications-rtis-gep.pdf. Accessed 25 Jan 2011
20. Machado ACS, Guimarães EMB, Sakurai E et al (2007) High titers of Chlamydia trachomatis antibodies in Brazilian women with tubal occlusion or previous ectopic pregnancy. Infect Dis Obstet Gynecol. doi:10.1155/2007/24816
21. Miller WC, Ford CA, Morris M et al (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291:2229-2236 (Pubitemid 38608172)
22. Araujo RSC, Guimaraes EMB, Alves MFC et al (2006) Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil. Eur J Clin Microbiol Infect Dis 25:397-400. doi:10.1007/s10096-006-0142-y (Pubitemid 43885685)
23. Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K (2004) Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis 31:542-546
24. WHO (2007) Global strategy for intervention and control of sexually transmitted infections 2006-2015. Geneva, World Health Organization. http://www.searo.who.int/LinkFiles/Publications-Global-Strategy-for-Prevention- and-Control-of-STIs-2006- 2015-Key-Messages.pdf. Accessed 15 Feb 2012
25. Krech T, Castriciano S, Jang D, Smieja M, Enders G, Chernesky M (2009) Detection of high-risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes. J Virol Methods 162:29-291. doi:10.1016/j.jviromet.2009.08.011
26. Wallin KL, Wiklund F, Luostarinen T et al (2002) A population-based prospective study of Chlamydia trachomatis infection and cervical cancer carcinoma. Int J Cancer 101:371-374 (Pubitemid 34987525)
27. Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S et al (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185:324-331 (Pubitemid 34107245)
28. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GV (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164. doi:10.1093/jnci/85.14.1159 (Pubitemid 23212283)
29. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M (eds) Molecular diagnostics of human cancer. Cold Spring Harbor, Cold Spring Harbor Laboratory, pp 209-214 (Cancer Cells Series, 7)
30. de Husman AMR, Walboomers JM, Van Den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Suppl 4):1057-1062
31. Gopalkrishna V, Aggarwal N, Malhotra VL, Koranne RV, Mohan VP, Mittal A, Das BC (2000) Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infect 6:88-93. doi:10.1046/j.1469-0691.2000. 00024.x (Pubitemid 36267448)
32. Oliveira ML, Amorim MMR, Souza PRE, Albuquerque LCB, Brandão LAC, Guimarães RLG (2008) Chlamydia infection in patients with and without cervical intra-epithelial lesions tested by real-time PCR vs. direct immunofluorescence. Braz J Infect Dis 12:324-328
33. Muñoz N, Castellsagué X, de González AB, Gissmann L (2006) HPV in the etiology of human cancer. Vaccine 24(Suppl l3):1-10. doi:10.1016/j.vaccine.2006.05.115
34. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890-907 (Pubitemid 47371147)
35. de Lima Soares V, de Mesquita AM, Cavalcante FG, Silva ZP, Hora V, Diedrich T, de Carvalho Silva P, de Melo PG, Dacal AR, de Carvalho EM, Feldmeier H (2003) Sexually transmitted infections in a female population in rural north-east Brazil: prevalence, morbidity and risk factors. Trop Med Int Health 8:595-603 (Pubitemid 36836503)
36. Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC (2003) Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat. Biomed Pharmacother 57:34-40 (Pubitemid 36315668)
37. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621-632. doi:10.1002/ijc.22527 (Pubitemid 46986496)
38. Clifford G, Fraceschi S, Diaz M, Muñoz N, Villa LL (2006) HPV type-distribution in women with and without cervical neoplastic disease. Vaccine 24:26-34. doi:10.1016/j.vaccine.2006.05.026
39. Bao YP, Li N, Smith JS, Qiao YL (2008) Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18:71-79
40. Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, Van de Wijgert JH, Oliveira RL, Diaz RS (2010) Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 21:105-109. doi:10.1258/ijsa.2009.008436
41. Fernandes JV, Meissner RV, Carvalho MG, Fernandes TA, Azevedo PR, Sobrinho JS, Prado JC, Villa LL (2010) Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Res Notes 3:96. doi:10.1186/1756-0500-3-96
42. Oliveira LH, Ferreira MD, Augusto EF, Melgaco FG, Santos LS, Cavalcanti SM, Rosa ML (2010) Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil. Rev Soc Bras Med Trop 43:4-8. doi:10.1590/S0037-86822010000100002
43. Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Lucena BR et al (2000) The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10:143-150 (Pubitemid 30351314)
44. Freitas TP, Carmo BB, Paula FD, Rodrigues LF, Fernandes AP, Fernandes PA (2007) Molecular detection of hpv 16 and 18 in cervical samples of patients from Belo Horizonte, Minas Gerais, Brazil. Rev Inst Med Trop 49:297-301. doi:10.1590/S0036-46652007000500005 (Pubitemid 350133452)
45. Baldez da Silva MF, Chagas BS, Guimaraes V, Katz LM, Felix PM, Miranda PM, Lima AA, Arraes LC, Martins DB, Lima Filho JL et al (2009) HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genet Mol Res 8:1437-1443
46. Oliveira-Silva M, Lordello CX, Zardo LMG, Bonvicino CR, Moreira MAM (2011) Human papillomavirus in Brazilian women with and without cervical lesions. Virol J 1:4-9. doi:10.1186/1743-422X-8-4
47. Muñoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1-5. doi:10.1016/S1386-6532(00)00125-6
48. Van Den Brule AJC, Pol R, Fransen-Daalmeijer N et al (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Micorbiol 40(3):779-787 (Pubitemid 34208623)
49. Levi JE, Kleter B, Quint WGV et al (2002) High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40:3341-3345. doi:10.1128/JCM.40.9.3341-3345.2002 (Pubitemid 34977451)
50. Gonçalves MA, Massad E, Burattni MN, Villa LL (1999) Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo. Brazil Int J STD AIDS 10:803-807. doi:10.1258/0956462991913583
51. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G (2008) Risk factors for human papillomavirus exposure and cofactors for cervical cancer in Latin America and the Caribbean Vaccine. 26(Suppl 11):L16-L36. doi:10.1016/j.vaccine.2008.06.008
52. Drain PK, Holmes KK, Hughes JP et al (2002) Determinants of cervical cancer rates in developing countries. Int J Cancer 100:199-205. doi:10.1002/ijc.10453 (Pubitemid 34666195)
53. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D et al (2005) Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162:668-675. doi:10.1093/aje/kwi262 (Pubitemid 41437366)
54. Silins I, Ryd W, Strand A, Wadell G, Törnberg S, Hansson BG et al (2005) Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116:110-115. doi:10.1002/ijc.20970 (Pubitemid 40827763)
55. Deluca GD, Basiletti J, Schelover E, Vásquez ND, Alonso JM, Marín HM, Lucero RH, Picconi MA (2011) Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina. Braz J Infect Dis 15(Suppl 6):567-572. doi:10.1016/S1413-8670(11)70252-5
56. Franceschi S, Smith JS, Van Den Brule A et al (2007) A cross-sectional study. Sex Transm Dis 34:563-569
57. Rodrigues E, Rodrigues L, Portugal V, Rodrigues N, Nápoles S, Casanova C (2011) Anogenital warts in children: the importance of a multidisciplinary approach. Acta Med Port 24:367-370
58. Cricca M, Venturoli S, Leo E et al (2009) Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions. J Virol Methods 158:180-183
59. Ramanakumar AV, Goncalves O, Richardson H et al (2010) Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis 10:326
60. Fernandes APM, Gonçalves MAG, Duarte G, Cunha FQ, Simões RT, Donadi EA (2005) HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology 334:294-298. doi:10.1016/j.virol.2005. 01.029
61. Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, Coutlée F (2008) Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol 43:307-312. doi:10.1016/j.jcv.2008.07.013
62. Sjoeborg KD, Tropé A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A (2010) HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol 118:29-31. doi:10.1016/j.ygyno. 2010.03.007
63. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY (2002) Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43:277-281 (Pubitemid 34874769)
64. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y (2006) Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35(3):264-269 (Pubitemid 43188971)
65. Chopjitt P, Ekalaksananan T, Pientong C, Kongyingyoes B, Kleebkaowc P, Charoensri N (2009) Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int J Infect Dis 13:212-219. doi:10.1016/j.ijid.2008.06.017
66. Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O (1985) Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol 92:1086-1092 (Pubitemid 16249338)
67. Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. Infect Dis 185:324-331 (Pubitemid 34107245)
68. Bhatla N, Puri K, Joseph E, Kriplani A, Venkateswaran KI, Sreenivas V (2013) Association of Chlamydia trachomatis infection with human papillomavuris (HPV) & cervical intraepithelial neoplasia - a pilot study. Indian J Med Res 137:533-539
69. Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD (2010) Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 102:1794-1804. doi:10.1093/jnci/djq436
70. Di Felice V, David S, Cappello F, Farina F, Zummo G (2005) Is Chlamydia l heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci 62:4-9 (Pubitemid 40933087)